These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15607432)

  • 1. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.
    Zieman SJ; Melenovsky V; Clattenburg L; Corretti MC; Capriotti A; Gerstenblith G; Kass DA
    J Hypertens; 2007 Mar; 25(3):577-83. PubMed ID: 17278974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.
    Vaitkevicius PV; Lane M; Spurgeon H; Ingram DK; Roth GS; Egan JJ; Vasan S; Wagle DR; Ulrich P; Brines M; Wuerth JP; Cerami A; Lakatta EG
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1171-5. PubMed ID: 11158613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
    Hartog JW; Willemsen S; van Veldhuisen DJ; Posma JL; van Wijk LM; Hummel YM; Hillege HL; Voors AA;
    Eur J Heart Fail; 2011 Aug; 13(8):899-908. PubMed ID: 21669961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
    Cooper ME
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-link breakers as a new therapeutic approach to cardiovascular disease.
    Susic D
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):853-6. PubMed ID: 17956231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of arterial stiffening: role of glycation - a mini-review.
    Sell DR; Monnier VM
    Gerontology; 2012; 58(3):227-37. PubMed ID: 22222677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-product cross-link breakers. A novel therapeutic pathway for cardiovascular disease.
    Hollenberg NK
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):21S-22S. PubMed ID: 15607431
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
    Yamagishi S
    Rejuvenation Res; 2012 Dec; 15(6):564-72. PubMed ID: 22950433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial.
    Oudegeest-Sander MH; Olde Rikkert MG; Smits P; Thijssen DH; van Dijk AP; Levine BD; Hopman MT
    Exp Gerontol; 2013 Dec; 48(12):1509-17. PubMed ID: 24400341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosslink breakers: a new approach to cardiovascular therapy.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Opin Cardiol; 2004 Jul; 19(4):336-40. PubMed ID: 15218393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.
    Asif M; Egan J; Vasan S; Jyothirmayi GN; Masurekar MR; Lopez S; Williams C; Torres RL; Wagle D; Ulrich P; Cerami A; Brines M; Regan TJ
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2809-13. PubMed ID: 10706607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Am J Hypertens; 2004 Apr; 17(4):328-33. PubMed ID: 15062886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alagebrium chloride protects the heart against oxidative stress in aging rats.
    Guo Y; Lu M; Qian J; Cheng YL
    J Gerontol A Biol Sci Med Sci; 2009 Jun; 64(6):629-35. PubMed ID: 19299252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase.
    Krautwald M; Leech D; Horne S; Steele ML; Forbes J; Rahmadi A; Griffith R; Münch G
    Rejuvenation Res; 2011 Aug; 14(4):383-91. PubMed ID: 21612515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.
    Shapiro BP; Owan TE; Mohammed SF; Meyer DM; Mills LD; Schalkwijk CG; Redfield MM
    Circulation; 2008 Sep; 118(10):1002-10. PubMed ID: 18711013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
    Candido R; Forbes JM; Thomas MC; Thallas V; Dean RG; Burns WC; Tikellis C; Ritchie RH; Twigg SM; Cooper ME; Burrell LM
    Circ Res; 2003 Apr; 92(7):785-92. PubMed ID: 12623881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):97-101. PubMed ID: 15032654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alagebrium (ALT-711) improves the anti-hypertensive efficacy of nifedipine in diabetic-hypertensive rats.
    Zhang B; He K; Chen W; Cheng X; Cui H; Zhong W; Li S; Wang L
    Hypertens Res; 2014 Oct; 37(10):901-7. PubMed ID: 24965174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ageing of the conduit arteries.
    Greenwald SE
    J Pathol; 2007 Jan; 211(2):157-72. PubMed ID: 17200940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.